U.S. Biotech Stock News

In the second quarter of 2026, NextEra Energy reported sales of US$7,534 million and net income of US$3,144 million, with diluted EPS from continuing operations rising to US$1.50 versus US$0.98 a year earlier. For the first half of 2026, the company’s sales increased to US$14,235 million and net income to US$5,326 million, while adjusted EPS of US$1.15 in Q2 exceeded analyst expectations despite revenue falling short of forecasts, underlining stronger profitability than many had...

EPR Properties (EPR) has secured a Fifth Amended, Restated and Consolidated Credit Agreement that introduces a US$1.0b senior unsecured revolving credit facility and a US$600.0m delayed draw term loan, reshaping its funding toolkit. See our latest analysis for EPR Properties. At a share price of US$63.53, EPR Properties has seen firm positive momentum, with a 30 day share price return of 7.79% and a year to date share price return of 25.16%, while its 5 year total shareholder return of 79.72%...

In recent days, analysts have reiterated positive views on Twilio ahead of its now-past 6 August 2026 earnings release, highlighting expectations for revenue and operating income above prior forecasts alongside enthusiasm for its SIGNAL 2026 AI-driven platform upgrades. A distinctive angle is the contrast between upbeat analyst sentiment around Twilio’s AI voice and messaging potential and increased insider selling, which may signal differing views on the company’s near-term prospects among...

Jack Henry & Associates recently prepared to report its Q4 earnings, with analysts expecting a double-digit year-over-year EPS decline, while Webster First Federal Credit Union integrated Jack Henry's Payrailz Pay a Person solution into its digital banking platform on July 7, 2026. This combination of an anticipated earnings slowdown alongside ongoing expansion of Jack Henry’s digital payments ecosystem offers a contrasting view of short-term pressure and longer-term product adoption. We’ll...

DRDGOLD (NYSE:DRD) has drawn fresh investor interest after appointing experienced chartered accountant Mark Hoffman as an independent non executive director and scheduling a special call to update investors on its Vision 2028 capital project. See our latest analysis for DRDGOLD. At a share price of $20.94, DRDGOLD has seen its short term momentum cool, with the 90 day share price return down 28.12% and the year to date share price return down 30.94%. This comes even though the 1 year total...

In July 2026, 1st Source Corporation reported past second-quarter and first-half results showing higher net interest income and net income, alongside improved earnings per share compared with a year earlier. The company also raised its quarterly cash dividend to US$0.45 per share and completed a share repurchase program totaling 571,389 shares for US$37.09 million, highlighting a combination of earnings strength and direct shareholder returns. With this backdrop of stronger earnings and a...

Rising US Treasury yields, renewed pressure from $100 oil, and new tariffs from the Trump administration are putting the spotlight back on big US financial stocks, where balance sheet strength and interest rate sensitivity can quickly matter more than headlines. With expectations building around the Federal Reserve’s next move, some large banks, insurers, and asset managers could find this mix of inflation, bond market moves, and trade tension either helpful or painful. This article explains...

Fresh interest in TE Connectivity (TEL) stock follows a busy stretch, with the company reporting third quarter results, continuing its buyback activity, and seeing increasing analyst optimism around its earnings outlook and valuation. See our latest analysis for TE Connectivity. Against this backdrop of strong third quarter results and ongoing buybacks, TE Connectivity’s 1 day share price return of 2.09% stands in contrast to a year to date share price decline of 12.98%. At the same time, the...

Union Pacific (UNP) has put solid numbers on the board for Q2 2026, with revenue of US$6.9 billion, basic EPS of US$3.36 and net income of US$2.0 billion. On a trailing twelve month basis, revenue sits at US$25.4 billion with basic EPS of US$12.36 and net income of US$7.3 billion. The company has seen quarterly revenue move from US$6.2 billion in Q1 2026 to US$6.9 billion in Q2 2026, alongside basic EPS rising from US$2.87 to US$3.36 over the same period. This gives investors a clear view of...

Elanco Animal Health stock has delivered a 107.8% return over the past three years, yet the current valuation checks and intrinsic value work suggest the shares may still be trading below what the business could be worth on fundamentals. Over the past three years, Elanco Animal Health has returned 107.8%, which puts recent price action front and center for anyone weighing up what is already reflected in the share price. For valuation, the key upside driver is how effectively Elanco Animal...

Progress Software stock has retreated over the past three years. On current checks it does not look obviously expensive or obviously cheap, which puts more weight on how investors read the latest moves around its valuation. The recent agreement to acquire Domo for US$400 million adds a fresh piece to that puzzle for anyone weighing what the current share price implies. Progress Software shares are down about 34.2% over three years, which suggests investors have become more cautious about the...

Recently, Toast drew attention as investors weighed its upcoming August 4, 2026 earnings release, which is expected to show higher earnings per share and revenue than the prior year, alongside debate over its valuation relative to peers. At the same time, comparisons with competitor Dave have highlighted Toast’s broad restaurant ecosystem, spanning payments, software, hardware, lending, and AI tools, as a key differentiator that could influence how its long-term business quality is...

Aktis Oncology (AKTS) has drawn investor attention after recent trading swings, with the stock down 4% over the past week and around 17% over the past month, despite year-to-date gains. See our latest analysis for Aktis Oncology. The recent 30 day share price return of down 16.8% has cooled earlier gains, even though the 90 day share price return of 12.4% and 6.7% year to date still point to fading, but not fully reversed, momentum for Aktis Oncology around the latest close at $23.89. If you...

Vor Biopharma stock has delivered a steeply negative 5 year return even after a recent rebound, and the low overall value score suggests the current share price of US$19.26 is not an obvious bargain based on the standard checks used here. Vor Biopharma has fallen 92.3% over 5 years, which puts the recent short term gains into the context of a share price that has already given up a large amount of value. Expectations around the company’s ability to translate its pipeline into sustainable...

Lufax Holding Ltd. recently announced that four directors, including executive director and chief financial officer Tongzhuan Xi, resigned citing personal work arrangements, while the company began a CFO search and reshuffled key board committee roles. At the same time, Lufax appointed veteran risk and governance specialist Wai Kin Chim as an independent non-executive director, potentially reshaping board oversight and control. We will now examine how the leadership reshuffle, particularly...

With inflation signals mixed, tariffs back in the headlines and borrowing costs still shaping consumer and business decisions, many investors are looking for stocks where analysts see clear earnings growth potential and balance sheets that can handle bumps in the road. That is exactly what the Healthy high growth potential screener aims to capture. It does this by filtering for companies where analysts expect strong earnings growth over the next 3 years and financial positions that meet...

Block (SQ) is back in focus after two restaurant and retail clients, Honolulu Cookie Company and Dimassi’s Mediterranean Buffet, expanded their use of Square’s software, hardware, and marketing tools across growing store networks. See our latest analysis for Block. Despite recent client wins, Block’s share price has moved in fits and starts, with a 90 day share price return of 7.71% and an 18.42% year to date share price return. The 5 year total shareholder return has declined 68.80%,...

Forgent Power Solutions (FPS) has drawn investor attention after reporting exceptionally strong demand tied to AI data centers and grid infrastructure, with record bookings and a nearly $2b backlog that supports revenue visibility and operational momentum. See our latest analysis for Forgent Power Solutions. Despite strong interest around AI data centers and grid projects, Forgent Power Solutions’ recent share price return has been mixed, with the stock down over the past month but still...

Recently, analysts grew more optimistic about Etsy’s upcoming quarterly earnings, pointing to the company’s history of outperforming estimates and a positive Earnings ESP alongside a favorable Zacks Rank. This shift in sentiment highlights how Etsy’s pattern of beating expectations is shaping perceptions of its earnings quality, rather than just its headline results. We’ll now examine how growing analyst optimism about another potential earnings beat could influence Etsy’s broader investment...

Spotify Technology (SPOT) is back in focus after the company reportedly removed more than 500,000 fake streams from Malcolm Todd’s “Earrings,” an episode tied to a regulated prediction market and potential legal questions. See our latest analysis for Spotify Technology. The share price of Spotify Technology has been volatile, with a 1-day share price return of 2.91% and a 30-day share price return of 6.08%. It is still down 16.06% year to date, and the 1-year total shareholder return has...

New US tariffs on imports from more than 60 economies are reshaping the risk profile for many global stocks, especially those built on complex cross border supply chains. Higher duties, possible retaliation, and added compliance hurdles can all eat into margins and unsettle earnings expectations. For investors, that can mean additional reasons to reassess which multinational companies might carry more risk than their share price suggests. This article looks at 3 stocks exposed to the latest...

Pinterest (PINS) is drawing fresh attention ahead of its second quarter earnings report, as investors weigh easier year ago comparisons against ongoing questions about ad monetization and the role of AI on the platform. See our latest analysis for Pinterest. At a share price of US$22.13, Pinterest has recently shown a 1 month share price return of 11.43% and a 3 month share price return of 11.09%. However, its 1 year total shareholder return is down 41.62%, which points to improving short...

Teladoc Health (TDOC) is back in focus after unveiling Teladoc One, an AI supported virtual care platform, just as new tools like ChatGPT Health raise questions about how patients seek digital health advice. See our latest analysis for Teladoc Health. Teladoc Health’s recent Teladoc One announcement and the spotlight on ChatGPT Health come after a strong 90 day share price return of 52.52% and a year to date share price return of 24.40%, while the 5 year total shareholder return is down...

Oscar Health stock has delivered a very large 3-year gain, yet the broader valuation checks paint a more mixed picture, with the shares currently screening as undervalued on market multiples but only middling on a composite value score. Over the last 3 years, Oscar Health has returned roughly 2.8x an investor's starting position. This puts recent moves in a longer-term context that matters for today's entry price. Expectations around how efficiently Oscar Health can scale its insurance...